Saliva has proven to be a discriminating element in forensic arenas, an effective indicator of acute diseases of salivary glands, and a promising probe for drug monitoring. With the advent of sensitive immunochemical assays, the compositional profile of human salivary secretions has been expanded considerably. Thus, the establishment of a range of "normal values" for a variety of "intrinsic" and "extrinsic" salivary components represented the initial step to use saliva as a diagnostic tool of oral health status. Unfortunately, numerous cross-sectional studies have shown a wide individual variation in the salivary composition of healthy populations, thus precluding its use as a diagnostic chair-side test for the screening of the most common chronic oral diseases (e.g., caries and periodontal disease). A possible explanation may arise from the wide functional versatility of salivary molecules. For instance, it has been recognized recently that in addition to its digestive properties, salivary amylase may modulate bacterial colonization, whereas histatins are not only antifungal but also bactericidal. Thus, low levels of already known antimicrobial salivary molecules (e.g., secretory IgA, lactoferrin, and lysozyme) could be compensated with higher concentrations of other molecules with antimicrobial activity, such as amylase and histatins. Consequently, for caries and periodontal diseases, longitudinal sialochemical studies may yield more insight than cross-sectional studies.
References
1.
Abramson, M., A.J. Barrett, G. Salvesen, and A. Grubb: Isolation of Six Cysteine Proteinase Inhibitors from Human Urine. J. Biol. Chem. 261:11282-11289 (1986).
2.
Aguirre, A., M.J. Levine, R.E. Cohen, and L.A. Tabak: Immunochemical Quantitation of α-Amylase and Secretory IgA in Parotid Saliva from People of Various Ages. Arch. Oral Biol. 32:297-301 (1987).
3.
Aguirre, A., B. Mendoza, M.S. Reddy, F.A. Scannapieco, and M.J. Levine: Lubrication of Selected Salivary Molecules and Artificial Salivas. Dysphagia4:95-100 (1989).
4.
Aguirre, A., L.A. Testa-Weintraub, J.A. Banderas, R. Dunford, and M.J. Levine: Levels of Salivary Cystatins in Periodontally Healthy and Diseased Older Adults. Arch. Oral Biol. 37:355-361 (1992).
5.
Anastasi, A., M.A. Brown, A.A. Kembhavi, M.J.H. Nicklin, C.A. Sayers, D. Sunter, and A.J. Barrett: Cystatin, a Protein Inhibitor of Cysteine Proteinases. Biochem. J. 211:129-138 (1983).
6.
Atkinson, J.A., C. Yeh, F.G. Oppenheim, D. Bermudez, B.J. Baum, and P.C. Fox: Elevation of Salivary Antimicrobial Proteins Following HIV-1 Infection. J. Acq. Imm. Def. Syn. 3:41-48 (1990).
7.
Barrett, A.J., N. Rawlings, M.E. Davies, W. Machleidt, G. Salvesen, and V. Turk: In: Proteinase Inhibitors, pp. 515-569. ( A. Barrett and G. Salvesen, Eds.) Elsevier, Amsterdam ( 1986).
8.
Baum, B.J.: Evaluation of Stimulated Parotid Saliva Flow Rate in Different Age Groups. J. Dent. Res. 60:1292-1296 (1981 ).
9.
Baum, B.J., E.E. Kousvelari, and F.G. Oppenheim: Exocrine Protein Secretion from Human Parotid Glands during Aging: Stable Release of the Acidic Proline-Rich Proteins. J. Gerodont. 37:392-395 (1982).
Block, P. and S. Brotman: A Method of Submaxillary Saliva Collection Without Cannulization. N. Y. State Dent. J. 28:116-118 (1962).
12.
Carlson, D.M.: Salivary Proline-Rich Proteins: Biochemistry, Molecular Biology and Regulation of Expression, Crit. Rev. Oral Biol. Med. 4(3/4): ( 1993).
13.
Clark, W.B., J.E. Beem, W.E. Nesbitt, J.O. Cisar, C.C. Tseng, and M.J. Levine: Pellicle Receptors for Actinomyces viscosus Type 1 Fimbriae In Vitro. Infect. Immun. 57:3003-3008 (1989 ).
14.
Clift, A. and C.M. Lamont: Saliva in Forensic Odontology. J. Forensic Sci. Soc. 14:241-245 (1974).
15.
Cohen, R.E., A. Aguirre, M.E. Neiders, M.J. Levine, P.C. Jones, M.S. Reddy, and J.G. Haar: Immunochemistry and Immunogenecity of Low Molecular Weight Human Salivary Mucin. Arch. Oral Biol. 36:347-356 (1991).
16.
Copeland, B.E.: Statistical Tools in Clinical Pathology. In: Clinical Diagnosis by Laboratory Methods, Ed. 15, pp. 1-14. ( I. Davidshon and J. B. Henry, Eds.) W. B. Saunders, Philadelphia (1974).
17.
Crawford, J.M., M.A. Taubman, and D.J. Smith: Minor Salivary Glands as a Major Source of Secretory Immunoglobulin A in the Human Oral Cavity. Science190:1206-1209 (1975).
18.
Denny, P.C.P., P.A. Denny, D.K. Klauser, S.H. Hong, M. Navazesh, and L.A. Tabak: Age-Related Changes in Mucins from Human Whole Saliva. J. Dent. Res. 70:1320-1327 (1991).
19.
DiPaola, C. and I.D. Mandel: Lactoferrin Concentration in Human Parotid Saliva as Measured by an Enzyme-Linked Immunosorbent Assay (ELISA). J. Dent. Res. 59:1463-1465 (1980).
20.
Douglas, C.W.I.: Characterization of the α-Amylase Receptor of Streptococcus gordonii NCTC 7868. J. Dent. Res. 69:1746-1752 (1990 ).
21.
Douglas, W.H., E.S. Reeh, N. Ramasubbu, P.A. Raj, K. Bhandary, and M.J. Levine: Statherin: A Major Boundary Lubricant of Human Saliva. Biochem. Biophys. Res. Commun. 180:91-97 (1991).
22.
Fox, P.C., P.F. van der Ven, B.J. Baum, and I.D. Mandel: Pilocarpine for the Treatment of Xerostomia Associated With Salivary Gland Dysfunction. Oral Surg. Oral Med. Oral Pathol. 61:243-248 (1986).
23.
Gibbons, R.J., D.I. Hay, and D.H. Schlesinger: Delineation of a Segment of Adsorbed Salivary Acidic Proline-Rich Proteins Which Promotes Adhesion of Streptococcus gordonii to Apatitic Surfaces. Infect. Immun. 59:2948-2954 (1991).
24.
Grahn, E., J. Tenovuo, O.-P. Lehtonen, E. Eerola, and P. Vilja: Antimicrobial Systems of Human Whole Saliva in Relation to Dental Caries, Cariogenic Bacteria and Gingival Inflammation in Young Adults. Acta Odontol. Scand. 46:67-74 (1988).
25.
Haeckel, R.: (1989): The Application of Saliva in Laboratory Medicine. J. Clin. Chem. Clin. Biochem.27:221-252 (1989).
26.
Hay, D.I., D.H. Schlesinger, and E.C. Moreno: Phosphoprotein Inhibitors of Calcium Phosphate Precipitation from Human Salivary Secretions. Inorg. Persp. Biol. Med. 2:271-285 (1979).
27.
Hay, D.I., D.J. Smith, S.K. Schluckebier, and E.C. Moreno: Relationship Between Concentration of Human Salivary Statherin and Inhibition of Calcium Phosphate Precipitation in Stimulated Human Parotid Saliva. J. Dent. Res. 63:857-863 (1984).
28.
Johnsson, M., C.F. Richardson, E.J. Bergey, M.J. Levine, and G.H. Nancollas: The Effects of Salivary Cystatins and Statherin on Hydroxyapatite Crystallization. Arch. Oral Biol. 31:631-636 (1991).
29.
Kessler, M.J., M.S. Reddy, R.H. Shah, and O.P. Bahl: Structures of N-Glycosidic Carbohydrate Units of Human Chorionic Gonadotropin. J. Biol. Chem. 254:7901-7908 (1979).
30.
Kirschbaum, C. and D.H. Hellhammer: Second European Symposium on Hormone and Drug Assessment in Saliva. Perspectives for Basic Research and Clinical Practice. J. Clin. Chem. Clin. Biochem. 28:649-666 (1990).
31.
Lamberts, B.L., K.M. Pruitt, E.D. Pederson, and M.P. Golding: Comparison of Salivary Peroxidase System Components in Caries-Free and Caries-Active Naval Recruits. Caries Res. 18:488-494 (1984).
32.
Lashley, K.S.: Reflex Secretion of the Human Parotid Gland. J. Exp. Psychol. 1:461 (1916).
33.
Levine, M.J., P.C. Jones, R.E. Loomis, M.S. Reddy, I. Al-Hashimi, E.J. Bergey, S.D. Bradway, R.E. Cohen, and L.A. Tabak: Functions of Human Saliva and Salivary Mucins: An Overview. In: Oral Mucosal Diseases: Biology, Etiology and Therapy, pp. 24-27. ( I. C. Mackenzie, C. A. Squier, and E. Dabelsteen, Eds.) Proceedings for the Second Dows Symposium, Laegeforeningens forlag, Copenhagen (1987).
34.
Levine, M.J., L.A. Tabak, M.S. Reddy, and I.D. Mandel: Nature of Salivary Pellicle in Microbial Adherence: Role of Salivary Mucins. In: Molecular Basis of Oral Microbial Adhesion, pp. 125-130. ( S. Mergenhagen and B. Rosan, Eds.) American Society for Microbiology, Washington, DC (1985).
35.
Mackay, B.J., L. Denepitiya, V.J. Iacono, S.B. Krost, and J.J. Pollock: Growth-Inhibitory and Bactericidal Effects of Human Parotid Salivary Histidine-Rich Polypeptides on Streptococcus mutans. Infect. Immun. 44:695-701 (1984).
36.
Mandel, I.D.: In Defense of the Oral Cavity. In: Proceedings Saliva and Dental Caries (Spec. Suppl.), pp. 473-49 ( I. Kleinberg, S. S. Ellison, and I. D. Mandel, Eds.) Microbiology Abstracts. Information Retrieval, New York (1979).
37.
Mandel, I.D.: Sialochemistry in Diseases and Clinical Situations Affecting Salivary Glands. CRC Clin. Lab. Sci. 12:321-366 (1980).
38.
Mandel, I.D., J. Behrman, R. Levy, and D. Weinstein: The Salivary Lactoperoxidase System in Caries-Resistant and Susceptible Adults. J. Dent. Res. 62:922-925 (1983).
39.
Mandel, I.D. and A. Bennick: Quantitation of Human Salivary Acidic Proline-Rich Proteins in Oral Diseases. J. Dent. Res. 62:943-945 (1982).
40.
Milne, R.W. and C. Dawes: Relative Contributions of Different Salivary Glands to the Blood Group Activity of Whole Saliva in Humans. Vox Sanguinis25:298-307 (1973).
41.
Murray, P.A., M.J. Levine, L.A. Tabak, and M.S. Reddy: Specificity of Salivary-Bacterial Interactions: II. Evidence for a Lectin on Streptococcus sanguis with Specificity for NeuAcα2,3Galβ1,3GalNAc Sequence. Biochem. Biophys. Res. Commun. 106:390-396 (1982).
42.
Murray, P.A., M.J. Levine, M.S. Reddy, L.A. Tabak, and E.J. Bergey: Preparation of Sialic Acid-Binding Protein from Streptococcus mitis KS32AR. Infect. Immun. 53:359-365 (1986).
43.
Oppenheim, F.G., Y.C. Yang, R.D. Diamond, D. Hyslop, G.D. Offner, and R.F. Troxler: The Primary Structure and Functional Characterization of the Neutral Histidine-Rich Polypeptide from Human Parotid Secretion. J. Biol. Chem. 261:1177-1182 (1986).
44.
Pollock, J.J., L. Denepitiya, B.J. Mackay, and V.J. Iacono: Fungistatic and Fungicidal Activity of Human Parotid Salivary Histidine-Rich Polypeptides on Candida albicans. Infect. Immun. 44:702-707 (1984).
45.
Prakobphol, A., M.J. Levine, L.A. Tabak, and M.S. Reddy: Purification of a Low-Molecular-Weight, Mucin-Type Glycoprotein from Human Submandibular-Sublingual (HSMSL) Saliva. Carbohydr. Res. 108:111-122 (1982).
46.
Prakobphol, A., H. Leffler, and S.J. Fisher: The High Molecular Weight Human Mucin Is the Primary Salivary Carrier of ABH, Lea and Leb Blood Group Antigens.Crit. Rev. Oral Biol. Med.4(3/4): (1993).
47.
Raj, P.A., M. Edgerton, and M.J. Levine: Salivary Histatin 5: Dependence of Sequence, Chain Length, and Helical Conformation for Candidacidal Activity. J. Biol. Chem. 265:3988-3905 (1990).
48.
Ramasubbu, N., M.S. Reddy, E.J. Bergey, G.G. Haraszthy, S.D. Soni, and M.J. Levine: Large-Scale Purification and Characterization of the Major Phosphoproteins and Mucins of Human Submandibular-Sublingual Saliva. Biochem. J. 280:341-352 (1991).
49.
Robinson, R., D.L. Kauffman, M.M. Wayne, M. Blum, A. Bennick, and P.J. Keller: Primary Structure and Possible Origin of the Non-Glycosylated Basic Proline-Rich Protein of Human Submandibular-Sublingual Saliva. Biochem. J. 263:497-503 (1989).
50.
Rudney, J.D.: Relationships Between Human Parotid Saliva Lysozyme, Lactoferrin, Salivary Peroxidase and Secretory Immunoglobulin A in a Large Sample Population. Arch. Oral Biol. 34:499-506 (1989).
51.
Rudney, J.D., K.C. Kajander, and Q.T. Smith: Correlations Between Salivary Levels of Total Protein, Lysozyme, Lactoferrin, Salivary Peroxidase, and Secretory Immunoglobulin A with Different Stimulatory States and Over Time. Arch. Oral Biol. 30:765-771 (1985).
52.
Scannapieco, F.A., E.J. Bergey, M.S. Reddy, and M.J. Levine: Characterization of Salivary a-Amylase Binding to Streptococcus sanguis. Infect. Immun. 57:2853-2863 (1989).
53.
Ship, J.A., P.C. Fox, and B.J. Baum: How Much Saliva Is Enough? J. Am. Dent. Assoc. 122:63-69 (1991).
54.
Shomers, J.P., L.A. Tabak, M.J. Levine, I.D. Mandel, and D.I. Hay: Properties of Cysteine Containing Phosphoproteins from Human Submandibular-Sublingual Saliva. J. Dent. Res. 61:397-401 (1982).
55.
Stuchell, R.N., M.S. Herrera, and I.D. Mandel: Immunochemical Quantitation of Human Submandibular-Sublingual Lysozyme. J. Immunol. Methods44:15-21 (1981).
56.
Stuchell, R.N. and I.D. Mandel: A Comparative Study in Caries-Resistant and Caries-Susceptible Adults. J. Dent. Res. 62:552-554 (1983).
57.
Tabak, L.A., M.J. Levine, I.D. Mandel, and S.A. Ellison: Role of Salivary Mucins in the Protection of the Oral Cavity. J. Oral Pathol. 11:1-17(1982).
58.
Tabak, L.A., I.D. Mandel, M. Herrera, and H. Baurmash: Changes in Lactoferrin and in Other Proteins in a Case of Chronic Recurrent Parotitis. J. Oral Pathol. 7:91-99 (1978).
59.
Towbin, H., T. Staehlin, and J. Gordon: Electrophoretic Transfer of Proteins from Polyacrylamide Gels to Nitrocellulose Sheets: Procedure and Some Applications. Proc. Natl. Acad. Sci. U.SA. 76:4350-4354 (1979).
60.
Virella, G. and J. Goudswaard: Measurement of Salivary Lysozyme. J. Dent. Res. 57:326-328 (1978).
61.
Warner, T.F. and E.A. Azen: Tannins, Salivary Proline-Rich Proteins and Oesophageal Cancer. Med. Hypotheses26:99-102 (1988).
62.
Wiesmann, U.N., T.F. Boat, and P.A. diSant Agnese: Flow Rates and Electrolytes in Minor Salivary Gland Saliva in Normal Subjects and Patients with Cystic Fibrosis. Lancet2:510 (1972).
63.
Wilton, J.M.A., M.A. Curtis, I.R. Gillett, G.S. Griffiths, M.F.J. Maiden, J.A.C. Sterne, D.T. Wilson, and N.W. Johnson: Detection of High-Risk Groups and Individuals for Periodontal Diseases: Laboratory Markers from Analysis of Saliva. J. Clin. Periodontol. 16:475-483 (1989).
64.
Wolf, R.O. and L.L. Taylor: The Concentration of Blood Group Substance in the Parotid, Sublingual and Submaxillary Salivas. J. Dent. Res. 43:272-275 (1964).
65.
Zahradnik, R.T., D. Propas, and E.C. Moreno: In Vitro Enamel Demineralization by Streptococcus mutans in the Presence of Salivary Pellicles. J. Dent. Res. 56:1107-1110 (1977).
